Exploiting antitumor immunity to overcome relapse and improve remission duration.
Chen LL; Chen X; Choi H; Sang H; Chen LC; Zhang H; Gouw L; Andtbacka RH; Chan BK; Rodesch CK; Jimenez A; Cano P; Jones KA; Oyedeji CO; Martins T; Hill HR; Schumacher J; Willmore C; Scaife CL; Ward JH; Morton K; Randall RL; Lazar AJ; Patel S; Trent JC; Frazier ML; Lin P; Jensen P; Benjamin RS; Cancer Immunology, Immunotherapy: CII, 2012, vol. 61, issue 7, p 1113, ISSN 14320851. ISBN 14320851.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef